Plasma genotyping in patients with non-small-cell lung cancer: simplifying or confusing the diagnosis? [0.03%]
非小细胞肺癌患者的血浆基因分型：简化还是混淆了诊断？
Satya Das,Leora Horn
Satya Das
The identification of driver mutations in patients with advanced non-small-cell lung cancer has changed the treatment outcomes for patients with actionable driver mutations. Lack of tissue at diagnosis, however, remains a central obstacle i...
Silvia Novello
Silvia Novello
Silvia Novello speaks to Roshaine Wijayatunga, Managing Commissioning Editor: Silvia Novello is a Full Professor of Medical Oncology in the Oncology Department at San Luigi Hospital in Orbassano, Italy, part of the University of Turin. She ...
Synchronous primary adenocarcinoma of the lung and pancreas: a case series and review of the literature [0.03%]
原发性肺和胰腺黏液腺癌的同期发生：病例系列及文献回顾
Akshjot Puri,Ly Ma,Gary V Walker et al.
Akshjot Puri et al.
Aim: The frequency of pancreatic cancer in association with cancer of other organs ranges from 1 to 20%, with the most common ones being gastric, colon, thyroid and genitourinary. The presence of synchronous lung and panc...
Case Reports
Lung cancer management. 2017 Jul;6(1):17-23. DOI:10.2217/lmt-2017-0003 2017
Added diagnostic utility of PET in a patient with subacute encephalopathy and small-cell lung cancer [0.03%]
一小细胞肺癌合并亚急性脑病患者中的正电子发射体层摄影(PET)诊断价值
Anjali Gera,David Olayinka Kamson,Victoria M Villaflor et al.
Anjali Gera et al.
Diagnosis of paraneoplastic neurologic disorder (PND) synthesizes the clinical picture (including the temporal relationship to the cancer diagnosis), detection of onconeural antibodies and exclusion of alternative causes. The mainstay of br...
Case Reports
Lung cancer management. 2017 Jul;6(1):9-16. DOI:10.2217/lmt-2016-0020 2017
Tamara A Sussman,Monica Khunger,Vamsidhar Velcheti
Tamara A Sussman
We report a case of crizotinib-induced esophageal ulcers in a 45-year-old woman with metastatic anaplastic lymphoma kinase-positive non-small-cell lung cancer after 10 weeks of therapy. Endoscopic and pathologic findings were consistent wit...
Case Reports
Lung cancer management. 2017 Jul;6(1):5-7. DOI:10.2217/lmt-2016-0017 2017
Stefania Vallone,Ingeborg Beunders,Ewelina Szmytke
Stefania Vallone
Yu Chen,Danai Khemasuwan,Michael J Simoff
Yu Chen
Since the success of the NLST study, the incorporation of lung cancer screening programs into current academic programs has been growing. Center for Medicare and Medicaid Services have acknowledged the importance and potential impact of lun...
Combination approaches in NSCLC involving immune checkpoint inhibitors [0.03%]
免疫检查点抑制剂在非小细胞肺癌联合治疗中的应用
Surein Arulananda,Gareth Rivalland,Thomas John
Surein Arulananda
Immune checkpoint inhibition has been proven to be highly efficacious in NSCLC and associated with durable responses in a limited number of patients. Chemotherapy and targeted therapies, which have also expanded rapidly in this field lead t...
AURA3 trial: does Tagrisso (osimertinib) have the potential to become the new standard of care for second-line treatment of patients with EGFR T790M mutation-positive locally advanced or metastatic NSCLC [0.03%]
阿来替尼(AURA3)研究：奥希替尼是否有可能成为EGFR T790M突变阳性局部晚期或转移性NSCLC二线治疗的标准疗法？
Vassiliki A Papadimitrakopoulou
Vassiliki A Papadimitrakopoulou
Vassiliki A Papadimitrakopoulou speaks to Roshaine Wijayatunga, Managing Commissioning Editor: Dr Papadimitrakopoulou is the Jay and Lori Eisenberg Distinguished Professor of Medicine and Chief of the section of Thoracic Medical Oncology in...
Roshaine A-M Wijayatunga
Roshaine A-M Wijayatunga